Literature DB >> 29273458

Testing environment shape differentially modulates baseline and nicotine-induced changes in behavior: Sex differences, hypoactivity, and behavioral sensitization.

J M Illenberger1, C F Mactutus1, R M Booze1, S B Harrod2.   

Abstract

In those who use nicotine, the likelihood of dependence, negative health consequences, and failed treatment outcomes differ as a function of gender. Women may be more sensitive to learning processes driven by repeated nicotine exposure that influence conditioned approach and craving. Sex differences in nicotine's influence over overt behaviors (i.e. hypoactivity or behavioral sensitization) can be examined using passive drug administration models in male and female rats. Following repeated intravenous (IV) nicotine injections, behavioral sensitization is enhanced in female rats compared to males. Nonetheless, characteristics of the testing environment also mediate rodent behavior following drug administration. The current experiment used a within-subjects design to determine if nicotine-induced changes in horizontal activity, center entries, and rearing displayed by male and female rats is detected when behavior was recorded in round vs. square chambers. Behaviors were recorded from each group (males-round: n=19; males-square: n=18; females-square: n=19; and females-round: n=19) immediately following IV injection of saline, acute nicotine, and repeated nicotine (0.05mg/kg/injection). Prior to nicotine treatment, sex differences were apparent only in round chambers. Following nicotine administration, the order of magnitude for the chamber that provided enhanced detection of hypoactivity or sensitization was contingent upon both the dependent measure under examination and the animal's biological sex. As such, round and square testing chambers provide different, and sometimes contradictory, accounts of how male and female rats respond to nicotine treatment. It is possible that a central mechanism such as stress or cue sensitivity is impacted by both drug exposure and environment to drive the sex differences observed in the current experiment. Until these complex relations are better understood, experiments considering sex differences in drug responses should balance characteristics of the testing environment to provide a complete interpretation of drug-induced changes to behavior.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavioral sensitization; Biological sex; Intravenous; Locomotor activity; Nicotine; Rats; Thigmotaxis

Mesh:

Substances:

Year:  2017        PMID: 29273458      PMCID: PMC6345557          DOI: 10.1016/j.pbb.2017.12.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  37 in total

1.  Course, severity, and treatment of substance abuse among women versus men.

Authors:  J Westermeyer; A E Boedicker
Journal:  Am J Drug Alcohol Abuse       Date:  2000-11       Impact factor: 3.829

2.  Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding.

Authors:  E C Donny; A R Caggiula; P P Rowell; M A Gharib; V Maldovan; S Booth; M M Mielke; A Hoffman; S McCallum
Journal:  Psychopharmacology (Berl)       Date:  2000-09       Impact factor: 4.530

3.  Behavioral sensitization following repeated intravenous nicotine administration: gender differences and gonadal hormones.

Authors:  R M Booze; M A Welch; M L Wood; K A Billings; S R Apple; C F Mactutus
Journal:  Pharmacol Biochem Behav       Date:  1999-12       Impact factor: 3.533

4.  Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Sheri Booth; Maysa A Gharib; Laure A Craven; Shannon S Allen; Alan F Sved; Kenneth A Perkins
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

Review 5.  A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature.

Authors:  Joseph R DiFranza; Robert J Wellman
Journal:  Nicotine Tob Res       Date:  2005-02       Impact factor: 4.244

6.  Sex differences in nicotine levels following repeated intravenous injection in rats are attenuated by gonadectomy.

Authors:  Steven B Harrod; Rosemarie M Booze; Charles F Mactutus
Journal:  Pharmacol Biochem Behav       Date:  2006-12-20       Impact factor: 3.533

Review 7.  Biological basis of sex differences in drug abuse: preclinical and clinical studies.

Authors:  Wendy J Lynch; Megan E Roth; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2002-09-05       Impact factor: 4.530

Review 8.  Nicotine discrimination in men and women.

Authors:  K A Perkins
Journal:  Pharmacol Biochem Behav       Date:  1999-10       Impact factor: 3.533

9.  Sex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors.

Authors:  Steven B Harrod; Charles F Mactutus; Klark Bennett; Ulla Hasselrot; Guanghan Wu; Marion Welch; Rosemarie M Booze
Journal:  Pharmacol Biochem Behav       Date:  2004-07       Impact factor: 3.533

10.  Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats.

Authors:  Brenda M Elliott; Martha M Faraday; Jennifer M Phillips; Neil E Grunberg
Journal:  Pharmacol Biochem Behav       Date:  2004-01       Impact factor: 3.533

View more
  2 in total

1.  Nicotine sensitization (part 1): estradiol or tamoxifen is required during the induction phase and not the expression phase to enable locomotor sensitization to nicotine in female rats.

Authors:  Jennet L Baumbach; Cheryl M McCormick
Journal:  Psychopharmacology (Berl)       Date:  2020-11-01       Impact factor: 4.530

2.  Sex-specific nicotine sensitization and imprinting of self-administration in rats inform GWAS findings on human addiction phenotypes.

Authors:  Alena Kozlova; Robert R Butler; Siwei Zhang; Thomas Ujas; Hanwen Zhang; Stephan Steidl; Alan R Sanders; Zhiping P Pang; Paul Vezina; Jubao Duan
Journal:  Neuropsychopharmacology       Date:  2021-05-18       Impact factor: 7.853

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.